Identity
- Security key
- 13922
- Ticker
- CV
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2025-07-02
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CV
Detail
Enriched 2026-08-14 20:47
- Market cap
- $342,750,199.96
- Shares outstanding (class)
- 49,963,586
- Shares outstanding (weighted)
- 49,963,586
- SIC
- 3845 ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
- Employees
- 99
- Location
- SARATOGA, CA
- Homepage
- https://www.capsovision.com
- Description
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.